A Study to Investigate RO7200220 in Diabetic Macular Edema
Recruiting
Study BP43445 is a phase II, multicenter, randomized, double-masked, active comparator-controlled study to investigate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7200220 administered intravitreally in participants with diabetic macular edema. Only one eye will be chosen as the study eye. The duration of the study will be up to 76 weeks.
Gender:
All
Ages:
18 years and above
Trial Updated:
11/02/2023
Locations: Deep Blue Retina PLLC, Southaven, Mississippi
Conditions: Diabetic Macular Edema